Market Closed -
OTC Markets
12:42:45 01/06/2024 am IST
|
5-day change
|
1st Jan Change
|
0.0521
USD
|
-5.96%
|
|
-21.42%
|
-47.05%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
68.5
|
24.39
|
58.58
|
40.45
|
53.18
|
28.63
|
-
|
-
|
Enterprise Value (EV)
1 |
68.5
|
24.39
|
58.58
|
40.45
|
53.18
|
63.73
|
55.93
|
28.63
|
P/E ratio
|
-
|
-2.33
x
|
14.5
x
|
-10
x
|
-
|
3.5
x
|
2
x
|
1.75
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
11
x
|
-
|
1.12
x
|
0.51
x
|
0.46
x
|
0.29
x
|
0.24
x
|
0.18
x
|
EV / Revenue
|
11
x
|
-
|
1.12
x
|
0.51
x
|
0.46
x
|
0.65
x
|
0.47
x
|
0.18
x
|
EV / EBITDA
|
-38.1
x
|
-
|
7.9
x
|
2.38
x
|
2.05
x
|
3.15
x
|
2.08
x
|
0.7
x
|
EV / FCF
|
-25.3
x
|
-
|
-
|
-
|
-
|
18.5
x
|
4.78
x
|
-
|
FCF Yield
|
-3.95%
|
-
|
-
|
-
|
-
|
5.41%
|
20.9%
|
-
|
Price to Book
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Nbr of stocks (in thousands)
|
3,42,504
|
3,48,489
|
4,03,990
|
4,04,484
|
4,09,039
|
4,09,039
|
-
|
-
|
Reference price
2 |
0.2000
|
0.0700
|
0.1450
|
0.1000
|
0.1300
|
0.0700
|
0.0700
|
0.0700
|
Announcement Date
|
25/05/20
|
14/04/21
|
22/04/22
|
24/04/23
|
29/04/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
6.2
|
-
|
52.45
|
79.33
|
116
|
98.5
|
119.2
|
156.7
|
EBITDA
1 |
-1.8
|
-
|
7.417
|
17.01
|
25.9
|
20.23
|
26.93
|
40.8
|
EBIT
1 |
-3.647
|
-
|
5.968
|
-0.714
|
1.412
|
6.7
|
12.9
|
-
|
Operating Margin
|
-58.82%
|
-
|
11.38%
|
-0.9%
|
1.22%
|
6.8%
|
10.83%
|
-
|
Earnings before Tax (EBT)
|
-
|
-
|
1.743
|
-4.462
|
-1.77
|
-
|
-
|
-
|
Net income
1 |
-
|
-9.21
|
1.743
|
-4.462
|
-1.77
|
8.65
|
16.65
|
-
|
Net margin
|
-
|
-
|
3.32%
|
-5.62%
|
-1.53%
|
8.78%
|
13.97%
|
-
|
EPS
2 |
-
|
-0.0300
|
0.0100
|
-0.0100
|
-
|
0.0200
|
0.0350
|
0.0400
|
Free Cash Flow
1 |
-2.704
|
-
|
-
|
-
|
-
|
3.45
|
11.7
|
-
|
FCF margin
|
-43.61%
|
-
|
-
|
-
|
-
|
3.5%
|
9.82%
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
17.05%
|
43.44%
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
39.88%
|
70.27%
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
25/05/20
|
14/04/21
|
22/04/22
|
24/04/23
|
29/04/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
---|
Net sales
1 |
14.02
|
16.65
|
18.56
|
18.32
|
25.8
|
27.14
|
30.89
|
30.19
|
27.73
|
20.95
|
23.73
|
26.07
|
27.77
|
28.6
|
30.55
|
EBITDA
1 |
1.45
|
2.459
|
3.23
|
4.259
|
7.061
|
6.765
|
7.302
|
6.702
|
5.136
|
3.589
|
4.7
|
5.7
|
6.2
|
6.4
|
7.3
|
EBIT
|
1.715
|
-3.382
|
-1.199
|
5.923
|
-2.055
|
0.171
|
-
|
-
|
-0.291
|
-
|
-
|
-
|
-
|
-
|
-
|
Operating Margin
|
12.23%
|
-20.31%
|
-6.46%
|
32.33%
|
-7.97%
|
0.63%
|
-
|
-
|
-1.05%
|
-
|
-
|
-
|
-
|
-
|
-
|
Earnings before Tax (EBT)
|
0.667
|
-4.372
|
-2.112
|
5.169
|
-3.147
|
-0.569
|
-
|
-
|
-1.191
|
-
|
-
|
-
|
-
|
-
|
-
|
Net income
|
0.654
|
-4.372
|
-2.112
|
5.169
|
-3.147
|
-0.569
|
-
|
-
|
-1.191
|
-
|
-
|
-
|
-
|
-
|
-
|
Net margin
|
4.67%
|
-26.26%
|
-11.38%
|
28.21%
|
-12.2%
|
-2.1%
|
-
|
-
|
-4.29%
|
-
|
-
|
-
|
-
|
-
|
-
|
EPS
2 |
0.0100
|
-0.0100
|
-0.0100
|
0.0100
|
-
|
-0.001400
|
-
|
-
|
-
|
-0.0100
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
22/04/22
|
25/05/22
|
18/08/22
|
15/11/22
|
24/04/23
|
29/05/23
|
29/10/23
|
16/11/23
|
29/04/24
|
29/05/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
35.1
|
27.3
|
-
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
1.735
x
|
1.014
x
|
-
|
Free Cash Flow
1 |
-2.7
|
-
|
-
|
-
|
-
|
3.45
|
11.7
|
-
|
ROE (net income / shareholders' equity)
|
-
|
-
|
-
|
-
|
-
|
11.6%
|
12.5%
|
-
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
-
|
-
|
4.2%
|
5.3%
|
-
|
Assets
1 |
-
|
-
|
-
|
-
|
-
|
206
|
314.2
|
-
|
Book Value Per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Cash Flow per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex
1 |
1.26
|
-
|
-
|
-
|
-
|
1.9
|
2.6
|
-
|
Capex / Sales
|
20.32%
|
-
|
-
|
-
|
-
|
1.93%
|
2.18%
|
-
|
Announcement Date
|
25/05/20
|
14/04/21
|
22/04/22
|
24/04/23
|
29/04/24
|
-
|
-
|
-
|
Last Close Price
0.07
CAD Average target price
0.3667
CAD Spread / Average Target +423.81% Consensus |
1st Jan change
|
Capi.
|
---|
| +37.29% | 602.09Cr | | -21.28% | 418.94Cr | | +4.52% | 325.49Cr | | -18.16% | 287.36Cr | | -7.70% | 237.49Cr | | +41.50% | 188.52Cr | | -4.05% | 157.98Cr | | -15.56% | 154.04Cr | | -14.62% | 150.16Cr |
Alternative Medicine
|